|
JAK2–KMT2A
(HGNC:6192, HGNC:7132)
|
MONDO:0004967
(MONDO:0004967)
|
strong |
strong |
moderate |
strong |
weak |
|
|
INSL3–MYCL
(HGNC:6086, HGNC:7555)
|
small cell lung carcinoma
(MONDO_0008433)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
ALK–KIF5B
(HGNC:427, HGNC:6324)
|
MONDO:0008903
(MONDO:0008903)
|
strong |
strong |
moderate |
strong |
weak |
|
|
IGH–MYC
(HGNC:5477, HGNC:7553)
|
Burkitt lymphoma
(MONDO_0007243)
|
strong |
moderate |
strong |
strong |
moderate |
|
|
IGH–BCL3
(HGNC:5477, HGNC:998)
|
MONDO:0004948
(MONDO:0004948)
|
strong |
moderate |
strong |
strong |
weak |
|
|
IGH–BCL2
(HGNC:5477, HGNC:990)
|
MONDO:0018908
(MONDO:0018908)
|
strong |
moderate |
moderate |
strong |
strong |
|
|
IGH–PAX5
(HGNC:5477, HGNC:8619)
|
MONDO:0004095
(MONDO:0004095)
|
strong |
weak |
moderate |
strong |
weak |
|
|
IGH–IGL
(HGNC:5477, HGNC:5853)
|
MONDO:0018908
(MONDO:0018908)
|
strong |
strong |
moderate |
strong |
weak |
|
|
IGH–MALT1
(HGNC:5477, HGNC:6819)
|
primary cutaneous marginal zone B-cell lymphoma
(MONDO_0015813)
|
strong |
weak |
moderate |
strong |
weak |
|
|
IGH–IGK
(HGNC:5477, HGNC:5715)
|
MONDO:0018874
(MONDO:0018874)
|
weak |
weak |
weak |
weak |
weak |
|
|
HOXD11–NUP98
(HGNC:5134, HGNC:8068)
|
acute myelomonocytic leukemia M4
(MONDO_0018871)
|
moderate |
moderate |
moderate |
moderate |
weak |
|
|
DNAJB1–PRKACA
(HGNC:5270, HGNC:9380)
|
MONDO:0006210
(MONDO:0006210)
|
strong |
moderate |
moderate |
strong |
weak |
|
|
HIP1–ALK
(HGNC:4913, HGNC:427)
|
lung adenocarcinoma
(MONDO_0005061)
|
strong |
strong |
moderate |
strong |
weak |
|
|
HOXD13–NUP98
(HGNC:5136, HGNC:8068)
|
MONDO:0018871
(MONDO:0018871)
|
strong |
moderate |
strong |
strong |
weak |
|
|
HOXC13–NUP98
(HGNC:5125, HGNC:8068)
|
MONDO:0018874
(MONDO:0018874)
|
moderate |
weak |
moderate |
strong |
weak |
|
|
HOXC11–NUP98
(HGNC:5123, HGNC:8068)
|
MONDO:0018874
(MONDO:0018874)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
HMGA2–NFIB
(HGNC:5009, HGNC:7785)
|
lipoma
(MONDO_0005106)
|
strong |
weak |
weak |
strong |
weak |
|
|
HMGA2–RAD51B
(HGNC:5009, HGNC:9822)
|
uterine corpus leiomyoma
(MONDO_0007886)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
DUX4–IGH
(HGNC:50800, HGNC:5477)
|
MONDO:0000870
(MONDO:0000870)
|
strong |
weak |
moderate |
strong |
weak |
|
|
HOXA9–NUP98
(HGNC:5109, HGNC:8068)
|
myeloid leukemia
(MONDO_0004643)
|
strong |
moderate |
strong |
strong |
moderate |
|